Profil
Meryle J.
Melnicoff is currently the Director at Friendship Bridge and the Director-Business Development at The Wistar Institute.
Previously, she worked as an Advisor at Ben Franklin Technology Partners.
Melnicoff received graduate and doctorate degrees from the University of Pennsylvania.
Aktiva positioner av Meryle J. Melnicoff
| Företag | Position | Start |
|---|---|---|
The Wistar Institute
The Wistar Institute BiotechnologyHealth Technology Provides biomedical research services | Företagsledare/Principal | - |
Friendship Bridge
Friendship Bridge Services to the Health IndustryHealth Services Operates charitable organization that creates opportunities to empower women | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Meryle J. Melnicoff
| Företag | Position | Slut |
|---|---|---|
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Tech Partners invests in companies located in the US. The firm focuses on IT, life sciences and physical sciences. It participates in seed and early-stage capital requirements. | Medlem av Investeringskommittén | - |
Meryle J. Melnicoffs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Friendship Bridge
Friendship Bridge Services to the Health IndustryHealth Services Operates charitable organization that creates opportunities to empower women | Health Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wistar Institute
The Wistar Institute BiotechnologyHealth Technology Provides biomedical research services | Health Technology |
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Tech Partners invests in companies located in the US. The firm focuses on IT, life sciences and physical sciences. It participates in seed and early-stage capital requirements. | Finance |
















